TELIX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Telix Pharmaceuticals Limited and Encourages Investors to Contact the Firm

(NASDAQ:TLX), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired Telix securities between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner […]

ATTENTION Prelude Therapeutics Incorporated (PRLD) Investors: Possible Fraud – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Prelude Therapeutics Incorporated ("Prelude Therapeutics Incorporated") (NASDAQ:PRLD) concerning possible violations of federal securities laws. Prelude issued a press release on November 4, 2025, announcing its decision to pause the clinical development of

ATTENTION Jefferies Financial Group Inc. (JEF) Investors: Possible Fraud – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Jefferies Financial Group Inc. ("Jefferies Financial Group Inc.") (NASDAQ:JEF) concerning possible violations of federal securities laws. On October 8, 2025, Jefferies announced that it and Point Bonita had approximately $715 million in

Lost Investment in Alkami Technology, Inc. (ALKT)? Levi & Korsinsky Launches Securities Fraud Investigation

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alkami Technology, Inc. ("Alkami Technology, Inc.") (NASDAQ:ALKT) concerning possible violations of federal securities laws. Alkami issued a press release on October 30, 2025, reporting its financial results for the third quarter of

Lost Money on Beyond Meat, Inc. (BYND)? Contact Levi & Korsinsky About Investigation

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Beyond Meat, Inc. ("Beyond Meat, Inc.") (NASDAQ:BYND) concerning possible violations of federal securities laws. Beyond Meat announced on October 24, 2025, that it "expects to record a non-cash impairment charge for the

TELIX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Telix Pharmaceuticals Limited and Encourages Investors to Contact the Firm

TELIX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Telix Pharmaceuticals Limited and Encourages Investors to Contact the Firm GlobeNewswire November 11, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their

MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:MRX), LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Marex Group plc (“Marex” or “the Company”) (NASDAQ: MRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm

MRX Investors Have Opportunity to Lead Marex Group plc Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire November 11, 2025 LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Marex Group plc (“Marex” or “the Company”) (NASDAQ:

Levi & Korsinsky Investigates Akebia Therapeutics, Inc. (AKBA) Over Possible Securities Fraud

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion

Baggallini Receives Accessories Council x Circana Growth Driver Award for Soho Backpack

The heritage travel and lifestyle brand celebrates 30 years, 30 million bags sold, and continued market momentum Baggallini, the globally recognized lifestyle and travel accessories brand, has been awarded the Circana Growth Driver Award by the Accessories Council at its annual Design Excellence Awards. The award celebrates brands demonstrating exceptional market performance, growth, and share

Scroll to Top